Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA |
ANCA Associated Vasculitis (AAV) | Phase2 | Brazil Israel Japan Saudi Arabia Singapore Switzerland United Kingdom United States View all |
NCT06868290 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors | Phase1, Phase2 | Australia Canada Czechia Denmark France Germany Israel Italy Japan Singapore South Korea Taiwan United States View all |
NCT06726148 |
Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab. |
Hidradenitis Suppurativa | United Arab Emirates | NCT06785675 | |
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab |
Relapsing Multiple Sclerosis (RMS) | Phase3 | Puerto Rico United States |
NCT06869785 |
Modifying PEST for Psoriatic Arthritis Screening |
Plaque Psoriasis, Psoriatic Arthritis | Na | Canada | NCT06382051 |
LATAM LOWERS LDL-C |
Hypercholesterolaemia | Phase4 | Argentina Brazil |
NCT06501443 |
Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa |
Hidradenitis Suppurativa | Phase3 | Argentina Austria Belgium Canada Colombia Czechia France Germany Greece Hungary Malaysia Poland Puerto Rico Romania Spain Turkey (Türkiye) United Kingdom United States View all |
NCT06840392 |
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis |
Generalized Myasthenia Gravis | Phase3 | Australia Belgium Canada China France India Japan Poland Romania South Korea Spain Taiwan United States View all |
NCT06744920 |
Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib. |
Chronic Myeloid Leukemia (CML) | Phase2 | France | NCT06514534 |
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia |
Familial Hypercholesterolemia - Homozygous | Phase3 | Austria China Greece Malaysia Netherlands South Africa Taiwan Turkey (Türkiye) United Kingdom United States View all |
NCT06597006 |